The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict ...

Although strategies for imaging angiogenesis are in the development phase, they have the potential to accelerate oncology drug development ... angiogenesis and anti-angiogenic treatment.

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

There is a bipartisan push in Congress to allow for anti-obesity drugs and services to be covered through a bill called the Treat and Reduce Obesity Act (TROA), but it failed to advance in the ...